If the EDC system is being used to collect clinical trial data that will be submitted to the FDA as evidence to be considered by the Agency in evaluation of a drug or device approval, the system would need to be Part 11 compliant in alignment with the Predicate rules for Part 312 (drugs) or Part 812 (devices).
